Donald Notman
Chief Operating Officer · OCULAR THERAPEUTIX, INC
- 2025
- Sep 2, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Donald Notman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Pravin Dugel - $1.94M in OCUL purchases and sales in the last 12 months
- Richard L. Md Lindstrom - $461K in OCUL purchases and sales in the last 12 months
- Namrata Saroj - $278K in OCUL purchases and sales in the last 12 months
- Nadia Waheed - $221K in OCUL purchases and sales in the last 12 months
- Jeffrey S. Heier - $204K in OCUL purchases and sales in the last 12 months
- Peter Kaiser - $187K in OCUL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Donald Notman?
Donald Notman is a corporate insider, tracked as Chief Operating Officer of OCULAR THERAPEUTIX, INC (OCUL). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Donald Notman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Donald Notman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($229K) across all tracked filings.
